1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA C9 CTRPv2 pan-cancer AAC -0.1 0.01
mRNA ANXA2R CTRPv2 pan-cancer AAC -0.095 0.01
mRNA FAM78B CTRPv2 pan-cancer AAC 0.1 0.01
mRNA PGC CTRPv2 pan-cancer AAC 0.089 0.01
mRNA AC129492.1 CTRPv2 pan-cancer AAC 0.09 0.01
mRNA SPN CTRPv2 pan-cancer AAC 0.12 0.01
mRNA MFAP1 CTRPv2 pan-cancer AAC -0.09 0.01
mRNA AC013461.1 CTRPv2 pan-cancer AAC -0.093 0.01
mRNA ZNF155 CTRPv2 pan-cancer AAC 0.092 0.01
mRNA ADPGK CTRPv2 pan-cancer AAC 0.098 0.01
Download CSV